epcoritamab
genmab,abbvie
['epcoritamab', 'lymsm']
catherine thieblemont ( ) of spoke with us at #eha2022 on a phase ii study evaluating subcutaneous epcoritamab in patients with r/r lbcl. watch her interview here: #hemonc #lymsm #immunoonc
The Video Journal of Hematological Oncology provides trusted information to improve knowledge of hematological cancers. VJHemOnc is intended for HCPs only.